ODTX Odyssey Therapeutics | 11/6/2026 | Initiated Coverage | $18.88 | $40.00 | Buy | $0.00 00.00% ROI | |
KARD Kardigan | 11/4/2026 | Initiated Coverage | $14.32 | $42.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 10/19/2026 | Reiterated Rating | $62.45 | $140.00 | Buy | $0.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 10/19/2026 | Reiterated Rating | $46.70 | $85.00 | Buy | $0.00 00.00% ROI | |
CLNN Clene | 10/19/2026 | Reiterated Rating | $3.24 | | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 10/15/2026 | Reiterated Rating | $331.65 | $361.00 | Buy | $0.00 00.00% ROI | |
BMEA Biomea Fusion | 10/14/2026 | Reiterated Rating | $1.26 | $4.00 | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 10/2/2026 | Reiterated Rating | $32.18 | $64.00 | Buy | $0.00 00.00% ROI | |
IOVA Iovance Biotherapeutics | 9/29/2026 | Boost Price Target | $13.75 | $20.00 | Buy | $0.00 00.00% ROI | |
NVCT Nuvectis Pharma | 9/24/2026 | Reiterated Rating | $21.02 | $39.00 | Buy | $0.00 00.00% ROI | |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
LGND Ligand Pharmaceuticals | 9/24/2026 | Reiterated Rating | $298.64 | $358.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 9/22/2026 | Reiterated Rating | $38.37 | | Buy | $0.00 00.00% ROI | |
ARMP Armata Pharmaceuticals | 9/22/2026 | Reiterated Rating | $4.26 | $15.00 | Buy | $0.00 00.00% ROI | |
ANAB AnaptysBio | 9/22/2026 | Reiterated Rating | $54.99 | $95.00 | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 9/22/2026 | Boost Price Target | $33.50 | $64.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 9/22/2026 | Reiterated Rating | $62.86 | $67.00 | Buy | $0.00 00.00% ROI | |
PHAR Pharming Group | 9/22/2026 | Reiterated Rating | $11.07 | $37.00 | Buy | $0.00 00.00% ROI | |
PHAR Pharming Group | 9/14/2026 | Reiterated Rating | $11.21 | $37.00 | Buy | $0.00 00.00% ROI | |
ANL Adlai Nortye | 9/8/2026 | Reiterated Rating | $15.62 | $20.00 | Buy | $0.00 00.00% ROI | |
SVA Sinovac Biotech | 9/8/2026 | Reiterated Rating | $6.47 | $1.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 8/31/2026 | Reiterated Rating | $72.09 | $140.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 8/26/2026 | Reiterated Rating | $0.22 | | Buy | $0.00 00.00% ROI | |
ANAB AnaptysBio | 8/24/2026 | Reiterated Rating | $56.98 | $95.00 | Buy | $0.00 00.00% ROI | |
BCDA BioCardia | 8/24/2026 | Reiterated Rating | $1.00 | | Buy | $0.00 00.00% ROI | |
CLNN Clene | 8/17/2026 | Reiterated Rating | $4.14 | | Buy | $0.00 00.00% ROI | |
OABI OmniAb | 8/17/2026 | Reiterated Rating | $3.93 | $11.00 | Buy | $0.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 8/14/2026 | Reiterated Rating | $41.66 | $85.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 8/14/2026 | Reiterated Rating | $73.45 | | Buy | $0.00 00.00% ROI | |
STTK Shattuck Labs | 8/11/2026 | Lower Price Target | $7.23 | $14.00 | Buy | $0.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 8/6/2026 | Boost Price Target | $312.13 | $358.00 | Buy | $0.00 00.00% ROI | |
QTTB Q32 Bio | 7/28/2026 | Boost Price Target | $15.21 | $36.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 7/27/2026 | Downgrade | $7.00 | | Neutral | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 7/14/2026 | Reiterated Rating | $1.22 | | Buy | $0.00 00.00% ROI | |
NVCT Nuvectis Pharma | 6/22/2026 | Boost Price Target | $13.80 | $39.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 6/16/2026 | Boost Price Target | $322.09 | $361.00 | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 6/15/2026 | Reiterated Rating | $31.27 | $42.00 | Buy | $0.00 00.00% ROI | |
NVCT Nuvectis Pharma | 6/12/2026 | Boost Price Target | $10.67 | $13.00 | Buy | $0.00 00.00% ROI | |
ANAB AnaptysBio | 6/10/2026 | Initiated Coverage | $51.63 | $95.00 | Buy | $0.00 00.00% ROI | |
BCDA BioCardia | 6/9/2026 | Reiterated Rating | $0.92 | $25.00 | Buy | $0.00 00.00% ROI | |
STTK Shattuck Labs | 6/8/2026 | Reiterated Rating | $4.93 | $18.00 | Buy | $0.00 00.00% ROI | |
Pentagon magnet restrictions take effect January 1, 2027 (Ad) A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It would build and operate a rare earth processing facility on an active military base, with the Army receiving first right to production.
The timing matters. New Pentagon restrictions on certain Chinese-origin rare earth magnets take effect January 1, 2027, while China controls more than 90% of global rare earth processing.
The company's mine-to-magnet platform spans feedstock agreements, processing facilities, metallization technology, and downstream manufacturing, with initial commercial output targeted for 2027. Read the full breakdown of the proposed Army rare earth agreement and the company behind it. |
GUTS Fractyl Health | 6/4/2026 | Reiterated Rating | $9.40 | $96.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 6/2/2026 | Boost Price Target | $43.12 | $67.00 | Buy | $0.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 6/2/2026 | Reiterated Rating | $29.86 | $57.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 6/1/2026 | Reiterated Rating | $309.03 | $310.00 | Buy | $0.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 5/22/2026 | Reiterated Rating | $29.19 | $57.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 5/18/2026 | Reiterated Rating | $306.29 | $310.00 | Buy | $0.00 00.00% ROI | |
PROK ProKidney | 5/18/2026 | Reiterated Rating | $1.63 | $12.00 | Buy | $0.00 00.00% ROI | |
LSTA Lisata Therapeutics | 5/15/2026 | Downgrade | $3.19 | | Neutral | $0.00 00.00% ROI | |
NEUP Neuphoria Therapeutics | 5/15/2026 | Downgrade | $4.74 | | Neutral | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 5/13/2026 | Reiterated Rating | $31.52 | $60.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 5/11/2026 | Boost Price Target | $76.91 | $140.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 5/5/2026 | Boost Price Target | $44.91 | $57.00 | Buy | $0.00 00.00% ROI | |
QTTB Q32 Bio | 5/5/2026 | Reiterated Rating | $5.00 | $13.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 5/4/2026 | Reiterated Rating | $278.00 | $310.00 | Buy | $0.00 00.00% ROI | |
CLNN Clene | 5/4/2026 | Reiterated Rating | $6.71 | $31.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 5/1/2026 | Downgrade | $3.12 | $3.16 | Neutral | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 4/30/2026 | Downgrade | $40.99 | $39.00 | Neutral | $0.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 4/30/2026 | Boost Price Target | $224.86 | $289.00 | Buy | $0.00 00.00% ROI | |
CMPX Compass Therapeutics | 4/27/2026 | Reiterated Rating | $1.92 | $24.00 | Buy | $0.00 00.00% ROI | |
GUTS Fractyl Health | 4/24/2026 | Reiterated Rating | $6.97 | $96.00 | Buy | $0.00 00.00% ROI | |
ANL Adlai Nortye | 4/20/2026 | Boost Price Target | $16.01 | $20.00 | Buy | $0.00 00.00% ROI | |
STTK Shattuck Labs | 4/20/2026 | Boost Price Target | $7.53 | $18.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 4/15/2026 | Reiterated Rating | $1.29 | $15.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 4/14/2026 | Reiterated Rating | $30.70 | $47.00 | Buy | $0.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 4/14/2026 | Boost Price Target | $230.97 | $243.00 | Buy | $0.00 00.00% ROI | |
CVKD Cadrenal Therapeutics | 4/7/2026 | Lower Price Target | $4.35 | $13.00 | Buy | $0.00 00.00% ROI | |
APRE Aprea Therapeutics | 3/31/2026 | Lower Price Target | $0.74 | $1.20 | Buy | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 3/24/2026 | Reiterated Rating | $1.44 | $9.00 | Buy | $0.00 00.00% ROI | |
PHAR Pharming Group | 3/24/2026 | Reiterated Rating | $16.08 | $37.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 3/23/2026 | Reiterated Rating | $32.33 | $102.00 | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 3/23/2026 | Reiterated Rating | $1.63 | $6.00 | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 3/20/2026 | Reiterated Rating | $28.76 | $97.00 | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 3/12/2026 | Set Price Target | $1.70 | $6.00 | | $0.00 00.00% ROI | |
PHAR Pharming Group | 3/12/2026 | Set Price Target | $15.64 | $37.00 | Buy | $0.00 00.00% ROI | |
QTTB Q32 Bio | 3/10/2026 | Reiterated Rating | $6.01 | $13.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 3/10/2026 | Reiterated Rating | $2.73 | | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 3/10/2026 | Reiterated Rating | $35.61 | $60.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 3/9/2026 | Downgrade | $7.10 | | Hold | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 3/6/2026 | Reiterated Rating | $1.91 | | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 3/5/2026 | Boost Price Target | $1.68 | $6.00 | Buy | $0.00 00.00% ROI | |
QTTB Q32 Bio | 2/25/2026 | Initiated Coverage | $4.50 | $13.00 | Buy | $0.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 2/24/2026 | Boost Price Target | $189.97 | $239.00 | Buy | $0.00 00.00% ROI | |
FBIO Fortress Biotech | 2/23/2026 | Reiterated Rating | $3.66 | $17.00 | Buy | $0.00 00.00% ROI | |
ARMP Armata Pharmaceuticals | 2/23/2026 | Boost Price Target | $9.25 | $15.00 | Buy | $0.00 00.00% ROI | |
NAMS NewAmsterdam Pharma | 2/19/2026 | Upgrade | $34.63 | | Strong-Buy | $0.00 00.00% ROI | |
ANL Adlai Nortye | 2/13/2026 | Upgrade | $9.64 | $16.00 | Buy | $0.00 00.00% ROI | |
APRE Aprea Therapeutics | 1/29/2026 | Reiterated Rating | $0.58 | $4.00 | Buy | $0.00 00.00% ROI | |
CALC CalciMedica | 1/29/2026 | Reiterated Rating | $1.25 | | Neutral | $0.00 00.00% ROI | |
KURA Kura Oncology | 1/13/2026 | Reiterated Rating | $9.17 | $40.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 1/9/2026 | Reiterated Rating | $248.91 | $310.00 | Buy | $0.00 00.00% ROI | |
Your father's savings lost half their value after 1971. (Ad) On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade.
Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction.
A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. Request the free guide in 30 seconds and get positioned now |
CYTK Cytokinetics | 12/22/2025 | Boost Price Target | $62.72 | $136.00 | Buy | $0.00 00.00% ROI | |
APRE Aprea Therapeutics | 12/18/2025 | Lower Price Target | $0.92 | $5.00 | Buy | $0.00 00.00% ROI | |
PROK ProKidney | 12/16/2025 | Initiated Coverage | $2.08 | $12.00 | Buy | $0.00 00.00% ROI | |
PROK ProKidney | 12/16/2025 | Initiated Coverage | $2.20 | $12.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 12/12/2025 | Lower Price Target | $0.79 | $3.00 | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 12/11/2025 | Lower Price Target | $26.13 | $97.00 | Buy | $0.00 00.00% ROI | |
NEUP Neuphoria Therapeutics | 12/5/2025 | Lower Price Target | $4.27 | $7.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 12/3/2025 | Boost Price Target | $27.67 | $60.00 | Buy | $0.00 00.00% ROI | |
NVCT Nuvectis Pharma | 12/3/2025 | Reiterated Rating | $5.81 | | Buy | $0.00 00.00% ROI | |
GUTS Fractyl Health | 12/2/2025 | Reiterated Rating | $17.70 | $96.00 | Buy | $0.00 00.00% ROI | |
STTK Shattuck Labs | 12/1/2025 | Upgrade | $2.06 | $6.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 11/28/2025 | Reiterated Rating | $36.26 | $47.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 11/25/2025 | Boost Price Target | $2.90 | $260.00 | Buy | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 11/24/2025 | Reiterated Rating | $1.75 | $9.00 | Buy | $0.00 00.00% ROI | |
KURA Kura Oncology | 11/14/2025 | Reiterated Rating | $10.68 | $40.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 11/13/2025 | Boost Price Target | $0.85 | $15.00 | Buy | $0.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 11/6/2025 | Boost Price Target | $208.50 | $231.00 | Buy | $000.00 00.00% ROI | |
FTH Sensei Biotherapeutics | 10/30/2025 | Downgrade | $10.06 | | Neutral | $00.00 00.00% ROI | |
IOVA Iovance Biotherapeutics | 10/29/2025 | Lower Price Target | $2.07 | $9.00 | Buy | $00.00 00.00% ROI | |
NAMS NewAmsterdam Pharma | 10/20/2025 | Initiated Coverage | $36.40 | $52.00 | Buy | $00.00 00.00% ROI | |
KURA Kura Oncology | 10/20/2025 | Reiterated Rating | $9.84 | $40.00 | Buy | $0.00 00.00% ROI | |
NAMS NewAmsterdam Pharma | 10/20/2025 | Initiated Coverage | $37.66 | $52.00 | Buy | $00.00 00.00% ROI | |
ATXS Astria Therapeutics | 10/16/2025 | Downgrade | $11.92 | | Hold | $0.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 10/8/2025 | Reiterated Rating | $27.36 | $57.00 | Buy | $00.00 00.00% ROI | |
KURA Kura Oncology | 9/30/2025 | Reiterated Rating | $8.97 | $40.00 | Buy | $00.00 00.00% ROI | |
VKTX Viking Therapeutics | 9/29/2025 | Reiterated Rating | $25.65 | $102.00 | Buy | $00.00 00.00% ROI | |
CYTK Cytokinetics | 9/29/2025 | Reiterated Rating | $52.79 | $120.00 | Buy | $00.00 00.00% ROI | |
GUTS Fractyl Health | 9/26/2025 | Lower Price Target | $15.86 | $96.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 9/25/2025 | Reiterated Rating | $6.47 | $24.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 9/22/2025 | Reiterated Rating | $48.66 | $120.00 | Buy | $00.00 00.00% ROI | |
BCDA BioCardia | 9/22/2025 | Reiterated Rating | $1.13 | $25.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 9/19/2025 | Reiterated Rating | $24.19 | $47.00 | Buy | $00.00 00.00% ROI | |
ESPR Esperion Therapeutics | 9/19/2025 | Reiterated Rating | $2.75 | $16.00 | Buy | $0.00 00.00% ROI | |
ATXS Astria Therapeutics | 9/17/2025 | Boost Price Target | $7.76 | $20.00 | Buy | $0.00 00.00% ROI | |
GUTS Fractyl Health | 9/15/2025 | Initiated Coverage | $12.24 | $108.00 | Buy | $0.00 00.00% ROI | |
ATYR aTyr Pharma | 9/15/2025 | Downgrade | $1.12 | | Neutral | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 9/15/2025 | Reiterated Rating | $153.21 | $240.00 | Buy | $000.00 00.00% ROI | |
CAPR Capricor Therapeutics | 9/11/2025 | Reiterated Rating | $6.30 | $24.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 9/10/2025 | Reiterated Rating | $27.53 | $47.00 | Buy | $00.00 00.00% ROI | |
TVTX Travere Therapeutics | 9/3/2025 | Reiterated Rating | $19.40 | $47.00 | Buy | $00.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 9/2/2025 | Reiterated Rating | $1.13 | $5.00 | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 9/2/2025 | Reiterated Rating | $1.11 | $4.00 | Buy | $0.00 00.00% ROI | |
TVTX Travere Therapeutics | 8/28/2025 | Boost Price Target | $17.44 | $47.00 | Buy | $00.00 00.00% ROI | |
LGND Ligand Pharmaceuticals | 8/28/2025 | Boost Price Target | $160.51 | $206.00 | Buy | $000.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 8/27/2025 | Reiterated Rating | $1.08 | $5.00 | Buy | $0.00 00.00% ROI | |
NEUP Neuphoria Therapeutics | 8/26/2025 | Reiterated Rating | $7.40 | $21.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 8/22/2025 | Reiterated Rating | $145.70 | $240.00 | Buy | $000.00 00.00% ROI | |
LSTA Lisata Therapeutics | 8/21/2025 | Reiterated Rating | $2.40 | $15.00 | Buy | $0.00 00.00% ROI | |
FBIO Fortress Biotech | 8/21/2025 | Lower Price Target | $2.05 | $17.00 | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 8/20/2025 | Lower Price Target | $24.02 | $42.00 | Buy | $00.00 00.00% ROI | |
Your Copy is on Hold (Claim it now) (Ad) James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play.
He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60.
Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date. Claim your copy of James Altucher's new Elon Musk report today. |
PHGE BiomX | 8/20/2025 | Reiterated Rating | $104.12 | $2,850.00 | Buy | $0.00 00.00% ROI | |
IOVA Iovance Biotherapeutics | 8/19/2025 | Reiterated Rating | $2.50 | $20.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 8/19/2025 | Reiterated Rating | $23.90 | $102.00 | Buy | $00.00 00.00% ROI | |
ATXS Astria Therapeutics | 8/13/2025 | Reiterated Rating | $6.65 | $16.00 | Buy | $0.00 00.00% ROI | |
FTH Sensei Biotherapeutics | 8/5/2025 | Reiterated Rating | $8.20 | $30.00 | Buy | $00.00 00.00% ROI | |
NVCT Nuvectis Pharma | 8/4/2025 | Lower Price Target | $7.01 | $10.00 | Buy | $00.00 00.00% ROI | |
YARW Yarrow Bioscience | 7/30/2025 | Downgrade | $0.39 | | Neutral | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 7/25/2025 | Reiterated Rating | $150.00 | $240.00 | Buy | $000.00 00.00% ROI | |
CAPR Capricor Therapeutics | 7/11/2025 | Lower Price Target | $7.94 | $24.00 | Buy | $00.00 00.00% ROI | |
TVTX Travere Therapeutics | 7/1/2025 | Reiterated Rating | $14.80 | $30.00 | Buy | $00.00 00.00% ROI | |
PDSB PDS Biotechnology | 7/1/2025 | Reiterated Rating | $1.33 | $13.00 | Buy | $0.00 00.00% ROI | |
EWTX Edgewise Therapeutics | 6/30/2025 | Initiated Coverage | $13.17 | $42.00 | Buy | $00.00 00.00% ROI | |
VKTX Viking Therapeutics | 6/25/2025 | Reiterated Rating | $26.08 | $102.00 | Buy | $00.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 6/24/2025 | Reiterated Rating | $0.73 | $4.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 6/24/2025 | Reiterated Rating | $1.52 | $4.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 6/24/2025 | Reiterated Rating | $8.47 | $77.00 | Buy | $00.00 00.00% ROI | |
KRYS Krystal Biotech | 6/24/2025 | Reiterated Rating | $143.72 | $240.00 | Buy | $000.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 6/23/2025 | Reiterated Rating | $0.95 | $9.00 | Buy | $0.00 00.00% ROI | |
CDTX Cidara Therapeutics | 6/18/2025 | Upgrade | $22.10 | $41.00 | Buy | $0.00 00.00% ROI | |
BLRX BioLineRx | 6/17/2025 | Reiterated Rating | $4.67 | | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 6/17/2025 | Reiterated Rating | $1.17 | $16.00 | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 6/13/2025 | Reiterated Rating | $20.35 | $50.00 | Buy | $00.00 00.00% ROI | |
CAPR Capricor Therapeutics | 6/13/2025 | Reiterated Rating | $12.51 | $77.00 | Buy | $00.00 00.00% ROI | |
ATXS Astria Therapeutics | 6/13/2025 | Reiterated Rating | $5.89 | $16.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 6/11/2025 | Reiterated Rating | $1.68 | $13.00 | Buy | $0.00 00.00% ROI | |
MBRX Moleculin Biotech | 6/9/2025 | Upgrade | $335.00 | $2,000.00 | Buy | $00.00 00.00% ROI | |
PHIO Phio Pharmaceuticals | 6/5/2025 | Initiated Coverage | $2.10 | $14.00 | Buy | $0.00 00.00% ROI | |
ATYR aTyr Pharma | 6/4/2025 | Reiterated Rating | $212.60 | $1,400.00 | Buy | $00.00 00.00% ROI | |
ANL Adlai Nortye | 6/2/2025 | Downgrade | $1.57 | | Neutral | $00.00 00.00% ROI | |
BLRX BioLineRx | 5/28/2025 | Reiterated Rating | $3.68 | | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 5/28/2025 | Reiterated Rating | $24.92 | $104.00 | Buy | $00.00 00.00% ROI | |
CRIS Curis | 5/19/2025 | Reiterated Rating | $40.60 | $340.00 | Buy | $0.00 00.00% ROI | |
ATYR aTyr Pharma | 5/19/2025 | Reiterated Rating | $130.80 | $1,400.00 | Buy | $00.00 00.00% ROI | |
ARMP Armata Pharmaceuticals | 5/19/2025 | Boost Price Target | $1.74 | $9.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 5/16/2025 | Lower Price Target | $107.10 | $2,850.00 | Buy | $0.00 00.00% ROI | |
CVKD Cadrenal Therapeutics | 5/16/2025 | Reiterated Rating | $15.14 | $32.00 | Buy | $0.00 00.00% ROI | |
CALC CalciMedica | 5/15/2025 | Reiterated Rating | $9.57 | $80.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 5/12/2025 | Reiterated Rating | $1.55 | $4.00 | Buy | $0.00 00.00% ROI | |
IOVA Iovance Biotherapeutics | 5/9/2025 | Lower Price Target | $3.17 | $20.00 | Buy | $0.00 00.00% ROI | |
ITRM Iterum Therapeutics | 5/8/2025 | Reiterated Rating | $0.92 | $9.00 | Buy | $0.00 00.00% ROI | |
BMEA Biomea Fusion | 5/6/2025 | Lower Price Target | $2.00 | $18.00 | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 5/6/2025 | Reiterated Rating | $20.29 | $80.00 | Buy | $00.00 00.00% ROI | |
KRYS Krystal Biotech | 5/6/2025 | Reiterated Rating | $141.18 | $240.00 | Buy | $000.00 00.00% ROI | |
NVCT Nuvectis Pharma | 4/30/2025 | Reiterated Rating | $10.33 | $15.00 | Buy | $0.00 00.00% ROI | |
KRYS Krystal Biotech | 4/28/2025 | Boost Price Target | $167.35 | $240.00 | Buy | $000.00 00.00% ROI | |
KURA Kura Oncology | 4/28/2025 | Reiterated Rating | $6.41 | $40.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 4/28/2025 | Reiterated Rating | $1.34 | $4.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 4/25/2025 | Reiterated Rating | $0.46 | $5.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 4/25/2025 | Reiterated Rating | $0.88 | $16.00 | Buy | $0.00 00.00% ROI | |
YARW Yarrow Bioscience | 4/25/2025 | Lower Price Target | $69.50 | $225.00 | Buy | $00.00 00.00% ROI | |
Drop these 5 stocks before the market opens tomorrow! (Ad) The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks.
A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out. See the five stocks Weiss Ratings analysts are watching closely now. |
VKTX Viking Therapeutics | 4/24/2025 | Reiterated Rating | $25.84 | $102.00 | Buy | $00.00 00.00% ROI | |
CMPX Compass Therapeutics | 4/21/2025 | Reiterated Rating | $1.78 | $24.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 4/21/2025 | Reiterated Rating | $38.01 | $120.00 | Buy | $00.00 00.00% ROI | |
VKTX Viking Therapeutics | 4/17/2025 | Reiterated Rating | $23.45 | $102.00 | Buy | $00.00 00.00% ROI | |
CYTK Cytokinetics | 4/15/2025 | Reiterated Rating | $39.07 | $120.00 | Buy | $00.00 00.00% ROI | |
TPST Tempest Therapeutics | 4/10/2025 | Reiterated Rating | $7.15 | $16.00 | Neutral | $0.00 00.00% ROI | |
XBIO Xenetic Biosciences | 4/9/2025 | Reiterated Rating | $2.38 | | Neutral | $0.00 00.00% ROI | |
CLNN Clene | 4/8/2025 | Reiterated Rating | $2.99 | $31.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 4/4/2025 | Reiterated Rating | $111.34 | $3,990.00 | Buy | $00.00 00.00% ROI | |
CMPX Compass Therapeutics | 4/4/2025 | Boost Price Target | $1.61 | $24.00 | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 4/4/2025 | Reiterated Rating | $40.52 | $120.00 | Buy | $00.00 00.00% ROI | |
KAPA Kairos Pharma | 4/3/2025 | Initiated Coverage | $6.43 | $84.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 4/1/2025 | Boost Price Target | $105.58 | $3,990.00 | Buy | $00.00 00.00% ROI | |
CALC CalciMedica | 4/1/2025 | Reiterated Rating | $9.55 | $80.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 4/1/2025 | Reiterated Rating | $1.61 | $4.00 | Buy | $0.00 00.00% ROI | |
BMEA Biomea Fusion | 3/31/2025 | Reiterated Rating | $2.30 | $40.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 3/31/2025 | Reiterated Rating | $0.61 | $5.00 | Buy | $0.00 00.00% ROI | |
BLRX BioLineRx | 3/31/2025 | Boost Price Target | $3.03 | $26.00 | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 3/28/2025 | Reiterated Rating | $20.97 | $104.00 | Buy | $00.00 00.00% ROI | |
TPST Tempest Therapeutics | 3/28/2025 | Lower Price Target | $10.92 | $208.00 | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 3/28/2025 | Reiterated Rating | $0.63 | $4.00 | Buy | $0.00 00.00% ROI | |
APTO Aptose Biosciences | 3/28/2025 | Boost Price Target | $3.33 | $6.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 3/27/2025 | Lower Price Target | $1.25 | $13.00 | Buy | $0.00 00.00% ROI | |
STTK Shattuck Labs | 3/27/2025 | Reiterated Rating | $1.07 | | Neutral | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 3/26/2025 | Reiterated Rating | $26.07 | $102.00 | Buy | $00.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 3/25/2025 | Reiterated Rating | $1.73 | $4.00 | Buy | $0.00 00.00% ROI | |
BMEA Biomea Fusion | 3/24/2025 | Reiterated Rating | $2.87 | $40.00 | Buy | $0.00 00.00% ROI | |
CLNN Clene | 3/24/2025 | Reiterated Rating | $4.06 | $31.00 | Buy | $0.00 00.00% ROI | |
XBIO Xenetic Biosciences | 3/20/2025 | Reiterated Rating | $3.64 | | Neutral | $0.00 00.00% ROI | |
PHAR Pharming Group | 3/20/2025 | Reiterated Rating | $8.86 | $37.00 | Buy | $00.00 00.00% ROI | |
ESPR Esperion Therapeutics | 3/20/2025 | Reiterated Rating | $1.62 | $16.00 | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 3/19/2025 | Reiterated Rating | $20.89 | $104.00 | Buy | $00.00 00.00% ROI | |
OABI OmniAb | 3/19/2025 | Reiterated Rating | $3.19 | $11.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 3/18/2025 | Reiterated Rating | $1.24 | $4.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 3/17/2025 | Reiterated Rating | $13.23 | $77.00 | Buy | $00.00 00.00% ROI | |
ATYR aTyr Pharma | 3/14/2025 | Reiterated Rating | $159.60 | $1,400.00 | Buy | $00.00 00.00% ROI | |
PHAR Pharming Group | 3/14/2025 | Reiterated Rating | $8.74 | $37.00 | Buy | $00.00 00.00% ROI | |
PDSB PDS Biotechnology | 3/13/2025 | Reiterated Rating | $1.27 | $21.00 | Buy | $0.00 00.00% ROI | |
CLNN Clene | 3/12/2025 | Reiterated Rating | $4.41 | $31.00 | Buy | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 3/11/2025 | Reiterated Rating | $0.53 | $9.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 3/11/2025 | Lower Price Target | $0.51 | $5.00 | Buy | $0.00 00.00% ROI | |
ATNM Actinium Pharmaceuticals | 3/11/2025 | Reiterated Rating | $1.12 | $4.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 3/11/2025 | Reiterated Rating | $25.36 | $102.00 | Buy | $00.00 00.00% ROI | |
ATXS Astria Therapeutics | 3/11/2025 | Reiterated Rating | $5.91 | $16.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 3/7/2025 | Reiterated Rating | $1.28 | $21.00 | Buy | $0.00 00.00% ROI | |
YARW Yarrow Bioscience | 3/6/2025 | Reiterated Rating | $115.50 | $287.50 | Buy | $00.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 3/5/2025 | Reiterated Rating | $22.08 | $57.00 | Buy | $00.00 00.00% ROI | |
CALC CalciMedica | 3/4/2025 | Reiterated Rating | $11.00 | $80.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 3/4/2025 | Reiterated Rating | $1.76 | $16.00 | Buy | $0.00 00.00% ROI | |
CAPR Capricor Therapeutics | 3/4/2025 | Reiterated Rating | $14.23 | $77.00 | Buy | $00.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 3/3/2025 | Reiterated Rating | $0.35 | $4.00 | Buy | $0.00 00.00% ROI | |
IOVA Iovance Biotherapeutics | 2/28/2025 | Reiterated Rating | $5.26 | $32.00 | Buy | $0.00 00.00% ROI | |
CLDX Celldex Therapeutics | 2/28/2025 | Reiterated Rating | $20.31 | $80.00 | Buy | $00.00 00.00% ROI | |
CYTK Cytokinetics | 2/28/2025 | Reiterated Rating | $47.45 | $120.00 | Buy | $00.00 00.00% ROI | |
KRYS Krystal Biotech | 2/28/2025 | Reiterated Rating | $176.56 | $221.00 | Buy | $000.00 00.00% ROI | |
KURA Kura Oncology | 2/27/2025 | Reiterated Rating | $7.77 | $40.00 | Buy | $0.00 00.00% ROI | |
ATXS Astria Therapeutics | 2/27/2025 | Reiterated Rating | $6.45 | $16.00 | Buy | $0.00 00.00% ROI | |
CLNN Clene | 2/25/2025 | Reiterated Rating | $4.33 | $31.00 | Buy | $0.00 00.00% ROI | |
NVCT Nuvectis Pharma | 2/25/2025 | Lower Price Target | $7.06 | $11.00 | Buy | $0.00 00.00% ROI | |
PDSB PDS Biotechnology | 2/24/2025 | Reiterated Rating | $1.23 | $21.00 | Buy | $0.00 00.00% ROI | |
YARW Yarrow Bioscience | 2/19/2025 | Reiterated Rating | $131.90 | $287.50 | Buy | $00.00 00.00% ROI | |
KRYS Krystal Biotech | 2/19/2025 | Reiterated Rating | $171.70 | $221.00 | Buy | $000.00 00.00% ROI | |
PTNT Palatin Technologies | 2/13/2025 | Lower Price Target | $54.25 | $350.00 | Buy | $0.00 00.00% ROI | |
APTO Aptose Biosciences | 2/12/2025 | Reiterated Rating | $6.70 | $60.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 2/11/2025 | Reiterated Rating | $1.86 | $16.00 | Buy | $0.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 2/11/2025 | Reiterated Rating | $0.64 | $9.00 | Buy | $0.00 00.00% ROI | |
PTNT Palatin Technologies | 2/7/2025 | Reiterated Rating | $49.50 | $850.00 | Buy | $0.00 00.00% ROI | |
KURA Kura Oncology | 2/6/2025 | Boost Price Target | $9.05 | $40.00 | Buy | $0.00 00.00% ROI | |
VKTX Viking Therapeutics | 2/6/2025 | Reiterated Rating | $33.50 | $102.00 | Buy | $00.00 00.00% ROI | |
NEUP Neuphoria Therapeutics | 2/4/2025 | Boost Price Target | $5.10 | $21.00 | Buy | $0.00 00.00% ROI | |
XOMA XOMA Royalty | 2/3/2025 | Lower Price Target | $26.61 | $104.00 | Buy | $00.00 00.00% ROI | |
LCTX Lineage Cell Therapeutics | 1/31/2025 | Reiterated Rating | $0.63 | $9.00 | Buy | $0.00 00.00% ROI | |
LXRX Lexicon Pharmaceuticals | 1/29/2025 | Reiterated Rating | $0.93 | $4.00 | Buy | $0.00 00.00% ROI | |
PTNT Palatin Technologies | 1/28/2025 | Reiterated Rating | $46.50 | $850.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 1/23/2025 | Reiterated Rating | $2.20 | $16.00 | Buy | $0.00 00.00% ROI | |
ATXS Astria Therapeutics | 1/23/2025 | Reiterated Rating | $7.53 | $16.00 | Buy | $00.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 1/22/2025 | Reiterated Rating | $21.29 | $57.00 | Buy | $00.00 00.00% ROI | |
CYTK Cytokinetics | 1/21/2025 | Reiterated Rating | $45.72 | $120.00 | Buy | $00.00 00.00% ROI | |
VKTX Viking Therapeutics | 1/17/2025 | Reiterated Rating | $33.66 | $102.00 | Buy | $00.00 00.00% ROI | |
APRE Aprea Therapeutics | 1/15/2025 | Reiterated Rating | $3.77 | $20.00 | Buy | $0.00 00.00% ROI | |
TNYA Tenaya Therapeutics | 1/14/2025 | Reiterated Rating | $1.50 | $18.00 | Buy | $0.00 00.00% ROI | |
RIGL Rigel Pharmaceuticals | 1/14/2025 | Reiterated Rating | $17.11 | $57.00 | Buy | $00.00 00.00% ROI | |
YARW Yarrow Bioscience | 1/14/2025 | Reiterated Rating | $151.00 | $287.50 | Buy | $00.00 00.00% ROI | |
BMEA Biomea Fusion | 1/14/2025 | Reiterated Rating | $4.15 | $40.00 | Buy | $0.00 00.00% ROI | |
ATXS Astria Therapeutics | 1/13/2025 | Reiterated Rating | $7.27 | $16.00 | Buy | $00.00 00.00% ROI | |
APTO Aptose Biosciences | 1/10/2025 | Reiterated Rating | $6.40 | $60.00 | Buy | $0.00 00.00% ROI | |
ESPR Esperion Therapeutics | 1/10/2025 | Reiterated Rating | $2.17 | | Buy | $0.00 00.00% ROI | |
CYTK Cytokinetics | 1/10/2025 | Reiterated Rating | $47.37 | $120.00 | Buy | $00.00 00.00% ROI | |
VKTX Viking Therapeutics | 1/8/2025 | Reiterated Rating | $41.52 | $102.00 | Buy | $00.00 00.00% ROI | |
CMPX Compass Therapeutics | 1/8/2025 | Reiterated Rating | $1.77 | $10.00 | Buy | $0.00 00.00% ROI | |
PHGE BiomX | 1/8/2025 | Reiterated Rating | $140.51 | $380.00 | Buy | $00.00 00.00% ROI | |